R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial

PURPOSE: Chemotherapy with or without radiotherapy is the standard in patients with initially nonmetastatic unresectable pancreatic cancer. Additional surgery is in discussion. The CONKO-007 multicenter randomized trial examines the value of radiotherapy. Our interim analysis showed a significant ef...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Strahlenther Onkol
Glavni autori: Fietkau, R., Grützmann, R., Wittel, U. A., Croner, R. S., Jacobasch, L., Neumann, U. P., Reinacher-Schick, A., Imhoff, D., Boeck, S., Keilholz, L., Oettle, H., Hohenberger, W. M., Golcher, H., Bechstein, W. O., Uhl, W., Pirkl, A., Adler, W., Semrau, S., Rutzner, S., Ghadimi, M., Lubgan, D.
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7801312/
https://ncbi.nlm.nih.gov/pubmed/32914237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00066-020-01680-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items